Efficacy and Safety of Osilodrostat in Managing Cushing’s Syndrome: A Systematic Review and Meta-Analysis

No meta-analysis has holistically analysed and summarized the efficacy and safety of osilodrostat, a novel dual 11β-hydroxylase (cytochrome P450 family 11 subfamily B member 1 [CYP11B1]) and 18-hydroxylase (aldosterone synthase, CYP11B2) inhibitor in managing Cushing’s syndrome (CS). We undertook th...

Full description

Bibliographic Details

Published in:	Indian Journal of Endocrinology and Metabolism
Main Authors:	Lakshmi Nagendra, Deep Dutta, Nishant Raizada, Vineet Surana, Chitra Selvan, Saptarshi Bhattacharya
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-06-01
Subjects:	adrenal cushing’s disease cushing’s syndrome osilodrostat pituitary
Online Access:	https://journals.lww.com/10.4103/ijem.ijem_260_23